2018, AbbVie, "FDA Grants AbbVie's Upadacitinib Breakthrough Therapy Designation for Atopic Dermatitis", Drug Discovery & Development Atopic dermatitis, a chronic inflammatory skin disease, is characterized by skin erosion, oozing and crusting, redness, intense itching (pruritus) and dry skin.
Source: wiktionary